newsfilter
← Latest News
GlobeNewswire·

Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference

BRISBANE, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer,